Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Dalrada Financial Corporation - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
DFCO
Over the counter
3841
https://dalrada.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Dalrada Financial Corporation
Dalrada Corporation Announces Authorized Share Reduction Highlighting Huge Growth Potential in 8-K Filing
- Mar 14th, 2024 12:00 pm
Dalrada Financial Corporation Announces $4.5 Million in Cost-Cutting Reductions to Accelerate Path to Profitability
- Mar 12th, 2024 12:00 pm
Dalrada Files 8-K; Chairman and CEO Shares Exciting News and Provides Future Outlook
- Feb 13th, 2024 1:00 pm
Dalrada Reports 54.3% Revenue Increase and Positive Net Equity in Annual 10-K
- Oct 19th, 2023 7:34 pm
Dalrada Technology Spain Reaches Distribution Agreement with JBS Consulting to Build and Install up to 2,300 Heat Pumps
- Sep 7th, 2023 1:30 pm
Dalrada Technology Spain Announces Agreement with Crown Glory Holding to Build and Install up to 4,500 Heat Pumps
- Sep 5th, 2023 1:30 pm
Dalrada Corporation Announces Further Global Expansion; Establishes Dalrada Technologies Morocco
- Aug 29th, 2023 1:30 pm
Trucept Announces 665% Increase In Operating Income
- Aug 21st, 2023 9:00 am
Genefic’s Achieve Weight-Loss and Wellness Enjoys Impressive Showing at Pharmacy Profit Summit 2023
- Aug 17th, 2023 1:30 pm
Dalrada’s Genefic Wellness Group Launches New Infusion Clinics to Deliver Successful Alternative Therapies
- Aug 8th, 2023 1:30 pm
Dalrada’s Genefic Launches Achieve Weight-Loss and Wellness to Target Emerging Weight Loss Market
- Aug 1st, 2023 1:30 pm
Dalrada’s Energy Services’ Subsidiary Licenses its Intellectual Property and Technical Knowledge to Pando Infrastructure
- Jul 26th, 2023 1:30 pm
Dalrada Pharmaceutical Subsidiary, Watson Rx Solutions, Earns Prestigious NABP Specialty Pharmacy and Digital Pharmacy Accreditation
- Jul 20th, 2023 1:30 pm
Dalrada Corporation Announces the Opening of its Heat Pump Showroom in Las Vegas
- Jul 18th, 2023 1:30 pm
Dalrada Continues Corporate Restructuring Efforts with Streamlined Operations and Leadership to Improve Subsidiary Interaction and Reduce SG&A
- Jul 13th, 2023 1:30 pm
Dalrada Corporation Announces Further European Expansion, Creates Dalrada Technology Spain, S.L.
- Jul 11th, 2023 1:30 pm
Dalrada Executes Corporate Restructuring to Increase Focus on Core Climate Technologies Business and Reduce SG&A by Approximately $3 Million Annually
- Jun 28th, 2023 1:00 pm
Watson Rx Solutions Earns Two Prestigious Pharmaceutical Accreditations from URAC
- May 22nd, 2023 1:30 pm
Dalrada Financial Corporation Reports Revenue of $9.5 Million, an Increase of over $4 Million or 80% During Q3 2023
- May 16th, 2023 1:30 pm
Dalrada Corporation Streamlines Board of Directors to Reflect US and Global Expansion
- May 11th, 2023 1:30 pm
Scroll